𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women

✍ Scribed by Wen-Ling Lee; Hsiang-Tai Chao; Ming-Huei Cheng; Peng-Hui Wang


Book ID
116731761
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
183 KB
Volume
60
Category
Article
ISSN
0378-5122

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Arzoxifene for prevention of fractures a
✍ Steven R Cummings; Michael McClung; Jean-Yves Reginster; David Cox; Bruce Mitlak πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 97 KB

## Abstract Arzoxifene is a selective estrogen receptor modulator (SERM) that has been shown to be more potent in preclinical testing than currently available agents. Its effects on clinical outcomes are not known. In a randomized, blinded trial, women aged 60 to 85 years with osteoporosis, defined